David M. Gershenson - Concepedia

Author

David M. Gershenson

The University of Texas MD Anderson Cancer Center

Also Known As

D M Gershenson, David M. Gershenson

Publications

959

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center

About

David M. Gershenson is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, obstetrics, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	692
2	Obstetrics	7	7	482
3	Pathology	2	2	321
4	Public Health	1	1	111
5	Pharmacology	1	1	38

David M. Gershenson

Publications

952

Citations

H-Index

Page 1

	Year	Citations
Intraoperative lymphatic mapping for vulvar cancer Charles Levenback, Thomas W. Burke, David M. Gershenson, International Journal of Gynecology & Obstetrics	1995	250
Intraoperative Lymphatic Mapping and Sentinel Node Identification with Blue Dye in Patients with Vulvar Cancer C. Levenback, Robert L. Coleman, Thomas W. Burke, Gynecologic Oncology Blue DyeVulvar DiseasesMedicineLymphatic SystemPathology	2001	210
The prognostic significance of peritoneal cytology for stage I endometrial cancer. Dennis A. Turner, David M. Gershenson, Nathan Atkinson, PubMed Surgical OncologyGynecological SurgeryPrecancerous LesionsCervical CancerCancer Detection	1989	111
Radical wide excision and selective inguinal node dissection for squamous cell carcinoma of the vulva Thomas W. Burke, C. Allen Stringer, David M. Gershenson, Gynecologic Oncology Surgical OncologyGynecological SurgerySquamous Cell CarcinomaGynecologySurgery	1990	109
Secondary cytoreductive surgery in epithelial ovarian cancer: Nonresponders to first-line therapy Mitchell Morris, David M. Gershenson, J. Taylor Wharton Gynecologic Oncology Gynecologic SurgerySurgical OncologySecondary Cytoreductive SurgeryFirst-line TherapyGynecological Surgery	1989	79
Phase II Trial of Vinorelbine in Recurrent and Progressive Epithelial Ovarian Cancer Robert A. Burger, Philip J. DiSaia, James A. Roberts, Gynecologic Oncology Phase Ii TrialMedicineGynecologyCancer TreatmentOncology	1999	69
Pelvic Exenteration for Primary and Recurrent Vulvar Cancer Brigitte Miller, Mitchell Morris, Charles Lev́enback, Gynecologic Oncology Surgical OncologyVulvar DiseasesGynecological SurgeryMedicinePelvic Prolapse	1995	64
A Phase I Study of a Daily ×3 Schedule of Intravenous Vinorelbine for Refractory Epithelial Ovarian Cancer David M. Gershenson, Thomas W. Burke, Mitchell Morris, Gynecologic Oncology OncologyIntravenous VinorelbineMedicineCancer ManagementGynecology	1998	38
A Phase II Study of Carboplatin and Cisplatin in Advanced or Recurrent Squamous Carcinoma of the Uterine Cervix Mitchell Morris, David M. Gershenson, Thomas W. Burke, Gynecologic Oncology Tumoral PathologyCervical CancerMalignant DiseaseMedicineGynecology	1994	12
Characterizing the genomic landscape through the lens of FOLR1 status in low and high grade serous ovarian carcinoma Tullia Rushton, Harris B. Krause, Timothy Samec, Gynecologic Oncology	2024	10

Page 1